Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
37.19
-1.01 (-2.64%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Edgewise Therapeutics Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Edgewise Therapeutics stock has a consensus rating of "Buy" and an average price target of $52.62. The average 1-year stock price forecast is 41.49% higher than the current stock price, while the lowest is $36 (-3.20%) and the highest is $66 (+77.47%).
Price Target: $52.62 (+41.49%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Edgewise Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 8 | 8 | 9 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 13 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $57 | Buy | Maintains | $57 | +53.27% | Oct 14, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $51 | Buy | Maintains | $51 | +37.13% | Oct 13, 2026 |
| Wedbush | Wedbush | Buy Maintains $53 | Buy | Maintains | $53 | +42.51% | Sep 23, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 23, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $36 | Hold | Maintains | $36 | -3.20% | Sep 23, 2026 |
Financial Forecast
Revenue This Year
139.58M
Revenue Next Year
42.73M
from 139.58M
Decreased by -69.39%
EPS This Year
1.38
from -1.63
EPS Next Year
-1.82
from 1.38
EPS and Forward PE are based on non-GAAP adjusted numbers.